EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II

(2016) Kesong Peng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?

(2016) Lena K Brahe et al.   Advances in Nutrition

EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model

(2015) Dandan Liang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal

(2015) Sarmishtha De et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease

(2015) Jane A. Leopold   TRENDS IN CARDIOVASCULAR MEDICINE

Impact of obesity on cardiac metabolism, fibrosis, and function

(2015) Rajiv Mahajan et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation

(2015) Ke Cao et al.   Scientific Reports

ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugs

(2014) Salvatore Patanè   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased Epidermal Growth Factor–Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide Phosphate Oxidase in a Primate Model of Atherosclerosis

(2012) Bojana Stanic et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus

(2012) Maria Galán et al.   HYPERTENSION

NF-κB, Inflammation, and Metabolic Disease

(2011) Rebecca G. Baker et al.   Cell Metabolism

Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice

(2011) William L. Holland et al.   JOURNAL OF CLINICAL INVESTIGATION

Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells

(2010) Dominique Thuringer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury

(2010) David Hsu et al.   LABORATORY INVESTIGATION

Targeting non-malignant disorders with tyrosine kinase inhibitors

(2010) Friedrich Grimminger et al.   NATURE REVIEWS DRUG DISCOVERY

Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice

(2009) Cordelia J. Barrick et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Macrophages and fibroblasts during inflammation, tissue damage and organ injury

(2009) Trevor Glaros   Frontiers in Bioscience-Landmark

Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signalling with innate immunity

(2008) Andreas Schaeffler et al.   IMMUNOLOGY

Helicobacter pyloriProtein HP0175 Transactivates Epidermal Growth Factor Receptor through TLR4 in Gastric Epithelial Cells

(2008) Sanchita Basu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway

(2008) David A. Bergin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY